1. MAPK/ERK Pathway PI3K/Akt/mTOR Epigenetics Anti-infection Immunology/Inflammation Cell Cycle/DNA Damage Vitamin D Related/Nuclear Receptor Metabolic Enzyme/Protease Apoptosis NF-κB
  2. p38 MAPK AMPK Bacterial Fungal Interleukin Related PPAR CDK PI3K Akt mTOR Apoptosis Reactive Oxygen Species (ROS)
  3. Sinigrin

Sinigrin  (Synonyms: 黑芥子苷; Allyl-glucosinolate; 2-Propenyl-glucosinolate)

目录号: HY-N0404 纯度: 99.92%
COA 产品使用指南 技术支持

Sinigrin (Allyl-glucosinolate) 是一种口服有效的存在于十字花科植物中的硫代葡萄糖苷。Sinigrin 具有抗癌、抗菌、抗真菌、抗炎抗氧化和抑制脂肪合成等多种活性。Sinigrin 可用于肿瘤、炎症性和代谢性等疾病的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Sinigrin Chemical Structure

Sinigrin Chemical Structure

CAS No. : 3952-98-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
5 mg ¥540
In-stock
10 mg ¥920
In-stock
25 mg ¥1770
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

Other Forms of Sinigrin:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Sinigrin (Allyl-glucosinolate) is an orally active glucosinolate found in cruciferous plants. Sinigrin possesses multiple activities such as anti-cancer, antibacterial, antifungal, anti-inflammatory, antioxidant, and inhibition of fat synthesis. Sinigrin can be used in the research of tumors, inflammatory, and metabolic diseases[1][2][3][4].

IC50 & Target[1][2]

PPARγ

 

IL-6

 

IL-1β

 

CDK4

 

CDK6

 

体外研究
(In Vitro)

Sinigrin (1-100 μg/mL; 1-8 days) 在 3T3-L1 细胞中可抑制脂质积累,下调脂肪生成相关基因的表达,抑制促炎细胞因子 (TNF-α、IL-6、IL-1β、IL-18) 的产生,并诱导细胞周期阻滞。机制涉及对 AMPK 通路的激活和 MAPK 通路的抑制[1]
Sinigrin (5-30 μM; 24-48 h) 在 MCF-7 细胞中通过抑制 PI3K/AKT/mTOR 磷酸化,诱导细胞周期阻滞于 S 期并促进凋亡,同时引发 ROS 依赖性氧化应激损伤[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis[1]

Cell Line: 3T3-L1 adipocytes
Concentration: 100 μg/mL
Incubation Time: 24 h
Result: Arrested cells in the G0/G1phase of the cell cycle and increased the expression of p21 and p27.

Western Blot Analysis[1]

Cell Line: 3T3-L1 adipocytes
Concentration: 1, 10, and 100 μg/mL
Incubation Time: 8 days
Result: Remarkably inhibited the accumulation of lipid droplets and adipogenesis by downregulating the expression of CCAAT-enhancer-binding protein α (C/EBPα), PPARγ, leptin and aP2.

RT-PCR[1]

Cell Line: 3T3-L1 adipocytes
Concentration: 1, 10, and 100 μg/mL
Incubation Time: 8 days
Result: Inhibited the production of pro-inflammatory cytokines including TNF-α and IL-6, IL-1β and IL-18.

Western Blot Analysis[2]

Cell Line: MCF-7 cells
Concentration: 20 μM
Incubation Time: 24 and 48 h
Result: Inhibited the levels of cyclin-D1, PCNA, CDK4, and CDK6.
体内研究
(In Vivo)

Sinigrin (15-30 mg/kg; 口服; 12 天) 在 DSS (HY-116282C) 诱导的溃疡性结肠炎小鼠模型中具有抗炎和改善作用[3]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male BALB/c mice (20-25 gm) treated DSS (HY-116282C)[3]
Dosage: 15 and 30 mg/kg
Administration: Oral administration; 12 days
Result: Significantly mitigated the DSS-induced body weight loss, attenuated the colon length shrinkage, and improved the disease index score.
Successfully abrogated the DSS-induced IL-17 levels and improved the colonic barrier in colon tissues.
分子量

397.46

Formula

C10H16KNO9S2

CAS 号
性状

固体

颜色

White to off-white

中文名称

黑芥子苷

结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

溶解性数据
细胞实验: 

H2O 中的溶解度 : 25 mg/mL (62.90 mM; 超声助溶)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.5160 mL 12.5799 mL 25.1598 mL
5 mM 0.5032 mL 2.5160 mL 5.0320 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

* 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
该产品水溶性佳,请具体参考实测 水 / PBS / Saline 中的溶解度数据。
您所需的储备液浓度超过该产品的实测溶解度,如有需要,请与 MCE 中国技术支持联系。
纯度 & 产品资料

纯度: 99.97%

参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
H2O 1 mM 2.5160 mL 12.5799 mL 25.1598 mL 62.8994 mL
5 mM 0.5032 mL 2.5160 mL 5.0320 mL 12.5799 mL
10 mM 0.2516 mL 1.2580 mL 2.5160 mL 6.2899 mL
15 mM 0.1677 mL 0.8387 mL 1.6773 mL 4.1933 mL
20 mM 0.1258 mL 0.6290 mL 1.2580 mL 3.1450 mL
25 mM 0.1006 mL 0.5032 mL 1.0064 mL 2.5160 mL
30 mM 0.0839 mL 0.4193 mL 0.8387 mL 2.0966 mL
40 mM 0.0629 mL 0.3145 mL 0.6290 mL 1.5725 mL
50 mM 0.0503 mL 0.2516 mL 0.5032 mL 1.2580 mL
60 mM 0.0419 mL 0.2097 mL 0.4193 mL 1.0483 mL

* 备注:如您选择水作为储备液,请稀释至工作液后,再用 0.22 μm 的滤膜过滤除菌后使用。

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Sinigrin
目录号:
HY-N0404
需求量: